PDGF enhances store-operated Ca2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells

A Ogawa, AL Firth, KA Smith… - American Journal of …, 2012 - journals.physiology.org
A Ogawa, AL Firth, KA Smith, MV Maliakal, JXJ Yuan
American Journal of Physiology-Cell Physiology, 2012journals.physiology.org
Platelet-derived growth factor (PDGF) and its receptor are known to be substantially
elevated in lung tissues and pulmonary arterial smooth muscle cells (PASMC) isolated from
patients and animals with pulmonary arterial hypertension. PDGF has been shown to
phosphorylate and activate Akt and mammalian target of rapamycin (mTOR) in PASMC. In
this study, we investigated the role of PDGF-mediated activation of Akt signaling in the
regulation of cytosolic Ca2+ concentration and cell proliferation. PDGF activated the …
Platelet-derived growth factor (PDGF) and its receptor are known to be substantially elevated in lung tissues and pulmonary arterial smooth muscle cells (PASMC) isolated from patients and animals with pulmonary arterial hypertension. PDGF has been shown to phosphorylate and activate Akt and mammalian target of rapamycin (mTOR) in PASMC. In this study, we investigated the role of PDGF-mediated activation of Akt signaling in the regulation of cytosolic Ca2+ concentration and cell proliferation. PDGF activated the Akt/mTOR pathway and, subsequently, enhanced store-operated Ca2+ entry (SOCE) and cell proliferation in human PASMC. Inhibition of Akt attenuated the increase in cytosolic Ca2+ concentration due to both SOCE and PASMC proliferation. This effect correlated with a significant downregulation of stromal interacting molecule (STIM) and Orai, proposed molecular correlates for SOCE in many cell types. The data from this study present a novel pathway for the regulation of Ca2+ signaling and PASMC proliferation involving activation of Akt in response to upregulated expression of PDGF. Targeting this pathway may lead to the development of a novel therapeutic option for the treatment of pulmonary arterial hypertension.
American Physiological Society